Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Antimicrobial resistance (AMR)
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Antimicrobial resistance (AMR)
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Research Articles

Latest Research Articles

Four-year-old Cheptete Lochariang’olei was bitten by a puff adder at 9 in the morning while playing outside their home in Nadome. Photograph by Paul Odongo
Research article
Research article |
26 October 2021
Tropical & neglected diseases

Toxicon: X: Access to antivenoms in the developing world: A multidisciplinary analysis

1 min
A nurse analyses a blood sample to perform a coagulation test following a snake bite at the Paoua hospital in northwestern Central African Republic, supported by MSF. Photograph by Alexis Huguet
Research article
Research article |
25 October 2021
Tropical & neglected diseases

BMJ Global Health: Snakebites and COVID-19: two crises, one R&D opportunity

1 min
Laboratory assistant Iuliia Karbivska is scanning an Xpert MTB/Rif cartridge for use in the GeneXpert machine provided by MSF for the laboratory of the Zhytomyr Regional TB Dispensary. Photograph by Oksana Parafeniuk
Research article
Research article |
31 August 2021
Tuberculosis

PLOS ONE: Public investments in the development of GeneXpert molecular diagnostic technology

2 min
Research article
Research article |
16 August 2016
Intellectual property and trade

Research & development in the dark: what does it take to make one medicine? And what could it take?

Research article |
07 April 2016
Tuberculosis

Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis

Research article
Research article |
18 November 2015
Hepatitis C

Disparity in market prices for hepatitis C virus direct-acting drugs

Research article
Research article |
04 November 2015
Tuberculosis

New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid

Research article
Research article |
10 September 2015
Tropical & neglected diseases
Central African RepublicSouth Sudan

Antivenoms for snakebite envenoming: what is in the research pipeline?

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury